Effect of treatment with direct acting antivirals on body mass index and hepatic steatosis in chronic hepatitis C

Journal of Medical Virology
Hend I ShoushaAyman Y Abdelrahim

Abstract

Direct Acting Agents (DAAs) have high cure rate but still lack the knowledge of their effect on hepatic steatosis in chronic hepatitis C (CHC). Controlled Attenuation Parameter (CAP), evaluated with transient elastography, could help in assessment of steatosis grades. We aim to evaluate the effect of DAAs on BMI and steatosis in CHC using CAP. This cohort study included 155 CHC Egyptian patients divided into three groups according to the DAAs regimens. All patients were subjected to pre-treatment and 3-months post-treatment evaluation including BMI, laboratory workup and liver stiffness measurement with simultaneous CAP determination using the (FibroScan®) M probe. Patients mean age was 45.78 ± 11.6 years, 60.6% were females, mean BMI 26.63 ± 2.75 and 18.1% were cirrhotic. Baseline assessment revealed no steatosis in 43.9%, 32.9% had mild-moderate steatosis and 23.2% had severe steatosis. The overall sustained virological response 12 was 93.6%. Follow-up revealed stationary steatosis in 56.7% of patients and regression in 21.3%. Mean pre-treatment CAP were significantly lower in responders 244.9 ± 62.4 dB/m versus non-responders; 300 ±28.4 dB/m (P = 0.04). ROC curve delineated 273 dB/m as best cutoff for detection of responders...Continue Reading

References

Aug 27, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Brian L BresslerJenny Heathcote
Oct 13, 2006·Liver International : Official Journal of the International Association for the Study of the Liver·M SoresiG Montalto
Jul 19, 2008·World Journal of Gastroenterology : WJG·Abdel-Rahman El-Zayadi
Dec 17, 2008·Gastroentérologie Clinique Et Biologique·V de Lédinghen, J Vergniol
Feb 27, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Don C RockeyUNKNOWN American Association for the Study of Liver Diseases
Mar 18, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Anna S LokUNKNOWN HALT-C Trial Group
Aug 22, 2009·Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology·G EsmatM El-Raziky
Sep 17, 2011·Clinics and Research in Hepatology and Gastroenterology·M SassoM Beaugrand
Sep 27, 2012·Arquivos De Gastroenterologia·Lucilene Rezende AnastácioMaria Isabel Toulson Davisson Correia
Jun 10, 2014·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Elliot B TapperNezam H Afdhal
Jun 27, 2014·World Journal of Gastroenterology : WJG·Amedeo LonardoPaola Loria
Aug 7, 2014·Arab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology·Imam WakedGamal Esmat
Sep 10, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Eric G MeissnerShyam Kottilil
Jan 29, 2016·World Journal of Gastroenterology : WJG·Ming-Ling Chang
Nov 4, 2016·Liver International : Official Journal of the International Association for the Study of the Liver·Jacqueline A BachofnerJoachim C Mertens
Feb 9, 2017·Journal of Gastroenterology and Hepatology·Aisha ElsharkawyGamal Esmat
Apr 14, 2017·The Lancet. Gastroenterology & Hepatology·UNKNOWN Polaris Observatory HCV Collaborators
Sep 9, 2017·Tropical Diseases, Travel Medicine and Vaccines·Heather L Stevenson, Netanya S Utay

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.